ALEVE

This brand name is authorized in Austria, Canada, Germany, Hong Kong SAR China, Malta, Netherlands, Poland, Singapore, South Africa, Turkey.

Active ingredients

The drug ALEVE contains one active pharmaceutical ingredient (API):

1	Naproxen UNII 9TN87S3A3C - NAPROXEN SODIUM
	Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis.
	Read more about Naproxen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALEVE Caplet / Capsule / Tablet	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE02	Naproxen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02301733, 02361795, 02436337
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07243674
HK	Department of Health Drug Office	51278
MT	Medicines Authority	AA274/01401
NL	Z-Index G-Standaard, PRK	17957, 33820, 50024
PL	Rejestru Produktów Leczniczych	100081892, 100378770, 100388700, 100397260, 100397626, 100399559, 100417702
SG	Health Sciences Authority	12440P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546098248
ZA	Health Products Regulatory Authority	31/2.7/0145